Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments

Late-phase clinical trials within diabetes generally have a duration of 12–24 weeks, where 12 weeks may be too short to reach steady-state glycated hemoglobin (HbA1c). The main determinant for HbA1c is blood glucose, which reaches steady state much sooner. In spite of this, few publications have use...

Descripción completa

Detalles Bibliográficos
Autores principales: Møller, J B, Overgaard, R V, Kjellsson, M C, Kristensen, N R, Klim, S, Ingwersen, S H, Karlsson, M O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817378/
https://www.ncbi.nlm.nih.gov/pubmed/24172651
http://dx.doi.org/10.1038/psp.2013.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817378/
https://www.ncbi.nlm.nih.gov/pubmed/24172651
http://dx.doi.org/10.1038/psp.2013.58

Ejemplares similares